• Explore /
  • Poster
  • / Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma.

Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma.

Abstract Video & Slides Poster

Authors

Joshua Reuss

Joshua E. Reuss

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Joshua E. Reuss , Boris Sepesi , Christian Diego Rolfo , Marianna Zahurak , Valsamo Anagnostou , Kellie Nicole Smith , Tricia Cottrell , Julie E. Stein , Peter Bela Illei , Janis M. Taube , Gary L. Rosner , Joseph Christopher Murray , Erica C. Nakajima , K Ranh Voong , Russell K. Hales , Stephen Yang , Richard James Battafarano , Joseph Friedberg , Anne S. Tsao , Patrick M. Forde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Mesothelioma

Clinical Trial Registration Number

NCT03918252

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS9078)

DOI

10.1200/JCO.2020.38.15_suppl.TPS9078

Abstract #

TPS9078

Poster Bd #

271

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Annual Meeting

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).

First Author: Aaron Scott Mansfield

First Author: Sakti Chakrabarti

First Author: Milton Jose De Barros E Silva

First Author: Yara L. Verschoor